pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·41m ago·1 min read
save

CHMP backs Novo’s hemophilia A drug and seven other medicines

Novo won regulatory backing for its hemophilia A preventive drug from the European Medicines Agency's human medicines committee, which also recommended approving seven other new drugs and 11 label expansions. The committee gives its opinions ...

Sep 18, 2026·read at Endpoints ↗

September 18, 2026 12:51 PM EDT Pharma CHMP backs No­vo’s he­mo­phil­ia A drug and sev­en oth­er med­i­cines Anna Brown News Reporter No­vo won reg­u­la­to­ry back­ing for its he­mo­phil­ia A pre­ven­tive drug from the Eu­ro­pean Med­i­cines Agency’s hu­man med­i­cines com­mit­tee, which al­so rec­om­mend­ed ap­prov­ing sev­en oth­er new … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
81 words · retrieved 2m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoFDA says initial rejections of new drugs have declinedEndpoints
  • 2h agoChina sets ambitious goals for global biopharma expansion in new five-year planEndpoints
  • 2h agoAnthropic starts verification program for using Mythos in biologyEndpoints
  • 6h agoLegend names new CEO as Carvykti competition grows; Vertex makes a flurry of movesEndpoints
  • 16h agoElectra's $350M IPO will help it become a commercial biotechEndpoints